Showing results (61-70 of 111) with videos related to

Sort By:
Pageof 12
Frontiers in Oncology|July 6, 2016
(13)C MRS and LC-MS Flux Analysis of Tumor Intermediary MetabolismAlexander A Shestov, Seung-Cheol Lee, Kavindra Nath, et al.
Molecular Immunology|August 5, 2011
IFN-α primes T- and NK-cells for IL-15-mediated signaling and cytotoxicityMikkel L Hansen, Anders Woetmann, Thorbjørn Krejsgaard, et al.
Diagnostic Pathology|December 21, 2016
Marginal zone lymphoma-derived interfollicular diffuse large B-cell lymphoma harboring 20q12 chromosomal deletion and missense mutation of BIRC3 gene: a case reportJoseph Hatem, April M Schrank-Hacker, Christopher D Watt, et al.
Heliyon|May 19, 2020
ACLY is the novel signaling target of PIP<sub>2</sub>/PIP<sub>3</sub> and Lyn in acute myeloid leukemiaJohnvesly Basappa, Mevlut Citir, Qian Zhang, et al.
Molecular Cancer Therapeutics|February 28, 2013
ALK inhibitor PF02341066 (crizotinib) increases sensitivity to radiation in non-small cell lung cancer expressing EML4-ALKYunguang Sun, Kamila A Nowak, Nicholas G Zaorsky, et al.
The Journal of Investigative Dermatology|February 25, 2011
Malignant cutaneous T-cell lymphoma cells express IL-17 utilizing the Jak3/Stat3 signaling pathwayThorbjørn Krejsgaard, Ulrik Ralfkiaer, Erik Clasen-Linde, et al.
The Journal of Investigative Dermatology|February 5, 2010
Deficient SOCS3 and SHP-1 expression in psoriatic T cellsKarsten W Eriksen, Anders Woetmann, Lone Skov, et al.
Blood|June 25, 2014
Staphylococcal enterotoxins stimulate lymphoma-associated immune dysregulationThorbjørn Krejsgaard, Andreas Willerslev-Olsen, Lise M Lindahl, et al.
Cold Spring Harbor Molecular Case Studies|September 20, 2023
Leukemic presentation and progressive genomic alterations of MCD/C5 diffuse large B-cell lymphoma (DLBCL)Patricia M Kim, Reza Nejati, Pin Lu, et al.
Blood|April 9, 2009
Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphomaThorbjørn Krejsgaard, Claudia S Vetter-Kauczok, Anders Woetmann, et al.
Pageof 12